Pharmaceuticals company Morepen Laboratories announced Q3FY26 results Revenue: Rs 48,416.1 lakh against Rs 45,278.01 lakh during Q3FY25, change 7%. PBT: Rs 3,542.12 lakh against Rs 3,520.59 lakh during Q3FY25, change 1%. PAT: Rs 2,749.55 lakh against Rs 2,668.85 lakh during Q3FY25, change 3%. EPS: Rs 0.5 for Q3FY26. Result PDF